🔶No. of vaccine doses administered- 25,07,556
🔷Active cases less than 1.75 lakhs
🔶Daily no. of deaths less than 125
🔷Cumulative positivity rate, 5.51% and declining: Secretary, @MoHFW_INDIA
Serum Institute of India, Pune submitted safety, immunogenicity, and efficacy data generated on 23,745 participants aged more than or equal to 18 years or older from overseas clinical studies. The overall vaccine efficacy was found to be 70.42%: DCGI
Bharat Biotech has developed a Whole Virion Inactivated Corona Virus Vaccine (Covaxin) in collaboration with @ICMRDELHI and NIV (Pune). This vaccine is developed on Vero cell platform, which has a well-established track record of safety & efficacy in the country & globally: DCGI
M/s Cadila Healthcare Ltd., has developed a Novel Corona Virus-2019-nCov-Vaccine using DNA platform technology. The interim data suggests that the vaccine is safe and immunogenic with three doses when administered intradermally: DCGI
#MissionKarmayogi will be a shift from Rules-based to Roles-based HR management linking training with development of competencies of civil servants with a big focus on e-learning